ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,127.63
-0.10%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Interpace Biosciences Inc (QX) (IDXG)

  7. Interpace Biosciences Inc (QX) (IDXG) News

Interpace Biosciences (QX) (IDXG)

Interpace Biosciences Inc (QX)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:IDXG
DateTimeSourceHeadlineSymbolCompany
09/05/202421:29Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
12/02/202422:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:IDXGInterpace Biosciences Inc (QX)
06/02/202411:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:IDXGInterpace Biosciences Inc (QX)
12/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
16/11/202321:05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
08/11/202322:14Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
08/11/202321:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IDXGInterpace Biosciences Inc (QX)
27/10/202321:05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
22/09/202321:53Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:IDXGInterpace Biosciences Inc (QX)
22/09/202321:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:IDXGInterpace Biosciences Inc (QX)
09/08/202320:47Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
09/08/202318:27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IDXGInterpace Biosciences Inc (QX)
01/08/202322:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:IDXGInterpace Biosciences Inc (QX)
12/05/202321:35Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
12/05/202321:24Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IDXGInterpace Biosciences Inc (QX)
03/05/202320:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:IDXGInterpace Biosciences Inc (QX)
28/04/202321:20Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:IDXGInterpace Biosciences Inc (QX)
27/03/202321:43Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
27/03/202321:40Edgar (US Regulatory)Annual Report (10-k)USOTC:IDXGInterpace Biosciences Inc (QX)
14/11/202222:28Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IDXGInterpace Biosciences Inc (QX)
14/11/202222:25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
04/11/202220:34Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
04/10/202221:20Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
20/09/202221:47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:IDXGInterpace Biosciences Inc (QX)
20/09/202221:37Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:IDXGInterpace Biosciences Inc (QX)
09/09/202221:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:IDXGInterpace Biosciences Inc (QX)
07/09/202221:46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
15/08/202222:46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
16/05/202222:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
16/05/202221:51Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IDXGInterpace Biosciences Inc (QX)
 Showing the most relevant articles for your search:USOTC:IDXG

Your Recent History

BIT
P1S2Z4
NLBNPIT1S2Z4 20240621 300
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved